Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vogler

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Blood|November 1, 1988
Leukemia of non-T lineage natural killer cellsW Sheridan, E F Winton, W C Chan, et al.
Leukemia & Lymphoma|January 1, 1996
High dose cyclophosphamide, fractionated total body irradiation with involved field irradiation and autologous bone marrow transplantation in malignant lymphomaM R Tirona, D S Gordon, I Crocker, et al.
American Journal of Hematology|June 1, 1985
Treatment of patients with acute nonlymphocytic leukemia in relapse: a Leukemia Intergroup studyJ Goldberg, H Grunwald, W R Vogler, et al.
American Journal of Hematology|April 1, 1993
Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemiaA Raza, H D Preisler, Y Q Li, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitroA W Himmelmann, S Danhauser-Riedl, G Steinhauser, et al.
Cancer Treatment Reports|October 1, 1977
Phase II Study of beta-2'-deoxythioguanosine in adult acute leukemiaG A Omura, W R Vogler, R V Smalley, et al.
British Journal of Haematology|November 1, 1991
The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failureH D Preisler, R A Larson, A Raza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group StudyW R Vogler, E Velez-Garcia, R S Weiner, et al.
The American Journal of Medicine|August 26, 1996
Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietinT H Price, L T Goodnough, W R Vogler, et al.
Transfusion|January 1, 1996
The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trialT H Price, L T Goodnough, W R Vogler, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Blood|November 1, 1988
Leukemia of non-T lineage natural killer cellsW Sheridan, E F Winton, W C Chan, et al.
Leukemia & Lymphoma|January 1, 1996
High dose cyclophosphamide, fractionated total body irradiation with involved field irradiation and autologous bone marrow transplantation in malignant lymphomaM R Tirona, D S Gordon, I Crocker, et al.
American Journal of Hematology|June 1, 1985
Treatment of patients with acute nonlymphocytic leukemia in relapse: a Leukemia Intergroup studyJ Goldberg, H Grunwald, W R Vogler, et al.
American Journal of Hematology|April 1, 1993
Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemiaA Raza, H D Preisler, Y Q Li, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitroA W Himmelmann, S Danhauser-Riedl, G Steinhauser, et al.
Cancer Treatment Reports|October 1, 1977
Phase II Study of beta-2'-deoxythioguanosine in adult acute leukemiaG A Omura, W R Vogler, R V Smalley, et al.
British Journal of Haematology|November 1, 1991
The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failureH D Preisler, R A Larson, A Raza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group StudyW R Vogler, E Velez-Garcia, R S Weiner, et al.
The American Journal of Medicine|August 26, 1996
Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietinT H Price, L T Goodnough, W R Vogler, et al.
Transfusion|January 1, 1996
The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trialT H Price, L T Goodnough, W R Vogler, et al.
Pageof 19